Get my own profile
Public access
View all75 articles
8 articles
available
not available
Based on funding mandates
Co-authors
Marina BacacRocheVerified email at roche.com
Guy GeorgesRoche Innovation Center MunichVerified email at roche.com
Ulrich BrinkmannRocheVerified email at roche.com
Hubert KettenbergerVerified email at roche.com
Sara ColombettiRoche Innovation Center Zurich-pREDVerified email at roche.com
Alfred ZippeliusProfessor of Translational Oncology, Co-Head Medical OncologyVerified email at usb.ch
Manfred SchwaigerHead of Operations, pRED Oncology, F. Hoffman-LaRoche Ltd.Verified email at roche.com
Daniela Stefanie ThommenDivision of Molecular Oncology and Immunology, The Netherlands Cancer InstituteVerified email at nki.nl
Andreas RollerRoche Pharma Research and Early Development (pRED)Verified email at roche.com
stefan endresLudwig-Maximilians-UniversitätVerified email at lmu.de
Lyubomir (Lubo) VassilevEMD Serono Research & Development Institute, Inc.Verified email at emdserono.com
Horst KesslerVerified email at tum.de
MJS DyerErnest and Helen Scott Haematological Research Institute, University of LeicesterVerified email at leicester.ac.uk
Mark CraggCentre for Cancer Immunology, University of SouthamptonVerified email at soton.ac.uk
Tapan NayakMerckVerified email at merck.com
Jean Jacques FourniéCentre de Recherches en Cancérologie de Toulouse, Universitré de Toulouse, PRESVerified email at inserm.fr
Alexander BujotzekRoche Innovation Center MunichVerified email at roche.com
Ysebaert LoicHematologistVerified email at iuct-oncopole.fr
Johannes BuchnerTUM Technical University of MunichVerified email at tum.de
Dr. Peter SondermannTacalyx GmbHVerified email at tacalyx.com
Follow![Christian Klein](https://scholar.googleusercontent.com/citations?view_op=view_photo&user=taccPg4AAAAJ&citpid=6)
Christian Klein
Roche Pharma Research and Early Development, Roche Innovation Center Zurich
Verified email at roche.com